MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.healun.2022.06.020

Медицинская библиотека · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2022

Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS.

Schwarz Stefan, Lang Christian, Harlander Matevz, Štupnik Tomaz, Slambrouck Jan Van, Ceulemans Laurens J, Ius Fabio, Gottlieb Jens, Kuhnert Stefan, Hecker Matthias, Aigner Clemens, Kneidinger Nikolaus, Verschuuren Erik Am, Smits Jacqueline M, Tschernko Edda, Schaden Eva, Faybik Peter, Markstaller Klaus, Trauner Michael, Jaksch Peter, Hoetzenecker Konrad

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Lung transplantation (LTx) can be considered for selected patients suffering from COVID-19 acute respiratory distress syndrome (ARDS). Secondary sclerosing cholangitis in critically ill (SSC-CIP) patients has been described as a late complication in COVID-19 ARDS survivors, however, rates of SSC-CIP after LTx and factors predicting this detrimental sequela are unknown.

METHODS

This retrospective analysis included all LTx performed for post-COVID ARDS at 8 European LTx centers between May 2020 and January 2022. Clinical risk factors for SSC-CIP were analyzed over time. Prediction of SSC-CIP was assessed by ROC-analysis.

RESULTS

A total of 40 patients were included in the analysis. Fifteen patients (37.5%) developed SSC-CIP. GGT at the time of listing was significantly higher in patients who developed SSC-CIP (median 661 (IQR 324-871) vs 186 (109-346); p = 0.001). Moreover, higher peak values for GGT (585 vs 128.4; p < 0.001) and ALP (325 vs 160.2; p = 0.015) were found in the 'SSC' group during the waiting period. Both, GGT at the time of listing and peak GGT during the waiting time, could predict SSC-CIP with an AUC of 0.797 (95% CI: 0.647-0.947) and 0.851 (95% CI: 0.707-0.995). Survival of 'SSC' patients was severely impaired compared to 'no SSC' patients (1-year: 46.7% vs 90.2%, log-rank p = 0.004).

CONCLUSIONS

SSC-CIP is a severe late complication after LTx for COVID-19 ARDS leading to significant morbidity and mortality. GGT appears to be a sensitive parameter able to predict SSC-CIP even at the time of listing.

Для цитирования: Schwarz Stefan, Lang Christian, Harlander Matevz, Štupnik Tomaz, Slambrouck Jan Van, Ceulemans Laurens J, Ius Fabio, Gottlieb Jens, Kuhnert Stefan, Hecker Matthias, Aigner Clemens, Kneidinger Nikolaus, Verschuuren Erik Am, Smits Jacqueline M, Tschernko Edda, Schaden Eva, Faybik Peter, Markstaller Klaus, Trauner Michael, Jaksch Peter, Hoetzenecker Konrad. Gamma-glutamyltransferase is a strong predictor of secondary sclerosing cholangitis after lung transplantation for COVID-19 ARDS.. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2022. DOI: 10.1016/j.healun.2022.06.020.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.